These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36130728)

  • 1. Non-small cell lung carcinomas with diffuse coexpression of TTF1 and p40: clinicopathological and genomic features of 14 rare biphenotypic tumours.
    Savari O; Febres-Aldana C; Chang JC; Fanaroff RE; Ventura K; Bodd F; Paik P; Vundavalli M; Saqi A; Askin FB; Travis WD; Rekhtman N
    Histopathology; 2023 Jan; 82(2):242-253. PubMed ID: 36130728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53, NOTCH2, and STK11 Mutations in a Rare Tumor of non-Small Cell Lung Carcinoma with Diffuse Coexpression of TTF1 and p40 in the Same Tumor Cells.
    Guo X; Dong L; Liu H; Chen X
    Int J Surg Pathol; 2023 Sep; 31(6):1041-1047. PubMed ID: 36253711
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinicopathological Characteristics and Prognosis Analysis of Lung Carcinoma With p40/TTF1 Coexpression and Lung Adenosquamous Carcinoma: Lung Carcinoma With p40/TTF1 Coexpression Is a Rare Tumor With High Metastatic Potential.
    Gao R; Zhang X; Chen X; Chen X; Jin L; Zheng H; Yu X
    Int J Surg Pathol; 2024 Oct; 32(7):1286-1291. PubMed ID: 38321785
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and ΔNp63/p40.
    Hayashi T; Takamochi K; Yanai Y; Mitani K; Tomita H; Mogushi K; Suehara Y; Takahashi F; Suzuki K; Saito T; Yao T
    Hum Pathol; 2018 Aug; 78():177-181. PubMed ID: 29410129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When tumor doesn't read textbook. Third case of TTF1 and p40 co-expression in the same tumour cells in a non-small cell carcinoma. A potential new entity to consider?
    Spinelli M; Khorshad J; Viola P
    Pathologica; 2019 Jun; 111(2):58-61. PubMed ID: 31388196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach.
    Pelosi G; Fabbri A; Bianchi F; Maisonneuve P; Rossi G; Barbareschi M; Graziano P; Cavazza A; Rekhtman N; Pastorino U; Scanagatta P; Papotti M
    J Thorac Oncol; 2012 Feb; 7(2):281-90. PubMed ID: 22071786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations.
    Pelosi G; Bulloni M; Vescio M; Uccella S; Forest F; Leone G; Barberis M; Rahal D; Bossi P; Finzi G; Marchiori D; De Luca M; Sessa F; Harari S; Spinelli M; Viola P; Macrì P; Maria S; Rizzo A; Picone A; Pattini L
    JTO Clin Res Rep; 2021 Nov; 2(11):100222. PubMed ID: 34746884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.
    Ao MH; Zhang H; Sakowski L; Sharma R; Illei PB; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2014 May; 45(5):926-34. PubMed ID: 24746197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse coexpression of thyroid transcription factor-1 and p40 in a non-small cell carcinoma of the lung: Second case in the female population.
    Segado Martínez M; Ruiz García G
    Rev Esp Patol; 2024; 57(2):120-122. PubMed ID: 38599731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients.
    Russell PA; Rogers TM; Solomon B; Alam N; Barnett SA; Rathi V; Williams RA; Wright GM; Conron M
    Pathology; 2017 Oct; 49(6):604-610. PubMed ID: 28811082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-small cell lung carcinoma with focal coexpression of thyroid transcription factor-1 and Δ Np63/p40: A case report.
    Terada K; Menju T; Date H; Haga H; Yoshizawa A
    Thorac Cancer; 2024 Apr; 15(12):1029-1033. PubMed ID: 38478955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge.
    Pelosi G; Fabbri A; Papotti M; Rossi G; Cavazza A; Righi L; Tamborini E; Perrone F; Settanni G; Busico A; Testi MA; Maisonneuve P; De Braud F; Garassino M; Valeri B; Sonzogni A; Pastorino U
    J Thorac Oncol; 2015 Nov; 10(11):1560-9. PubMed ID: 26317919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
    Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
    Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
    Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
    Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.
    Perner S; Wagner PL; Soltermann A; LaFargue C; Tischler V; Weir BA; Weder W; Meyerson M; Giordano TJ; Moch H; Rubin MA
    J Pathol; 2009 Jan; 217(1):65-72. PubMed ID: 18932182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of dual-marker staining to differentiate between lung squamous cell carcinoma and adenocarcinoma.
    Guo R; Tian Y; Zhang N; Huang H; Huang Y; Yang J
    J Int Med Res; 2020 Apr; 48(4):300060519893867. PubMed ID: 31880186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
    Yu H; Pang Z; Li G; Gu T
    J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis.
    Rodriguez EF; VandenBussche CJ; Chowsilpa S; Maleki Z
    Cancer Cytopathol; 2018 Oct; 126(10):853-859. PubMed ID: 30199148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of a Novel Immunohistochemical Triple Cocktail in the Subclassification of Resected Non-Small Cell Lung Carcinomas: A Comparative Study With Morphology and Traditional Immunohistochemistry.
    HooKim K; Chaudoir CS; Chaudhery SI; Reid MD
    Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):27-34. PubMed ID: 27258567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.
    Cardnell RJ; Behrens C; Diao L; Fan Y; Tang X; Tong P; Minna JD; Mills GB; Heymach JV; Wistuba II; Wang J; Byers LA
    Clin Cancer Res; 2015 Aug; 21(15):3480-91. PubMed ID: 25878335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.